Moreover, miR-181a-5p and miR-324-5p could reduce proliferative and angiogenic responses in patient-derived cells and attenuates disease progression in PAH mice, showing the potential therapeutic role of KLF2-regulated exosomal miRNAs in PAH [38]. This evidence concerns the gene KLF2 and pulmonary arterial hypertension.